FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000415450> ?p ?o ?g. }

• W2000415450 abstract "PI3K inhibitors have shown promise for the treatment of anti-estrogen-resistant breast cancers. Dose determination in clinical studies is often performed in a dose-escalation fashion until toxicities are observed; however, this approach does not provide information on target inhibition or allow optimization of scheduling for maximal anti-cancer effects. Current PI3K inhibitor treatment regimens incompletely and transiently inhibit the pathway in carcinomas, and are accompanied by adverse effects in patients. We hypothesize that short-term, complete inhibition of PI3K will have a greater anti-tumor effect and reduced adverse effects than chronic, partial inhibition. Through detailed analysis of the timing and magnitude of drug effects on tumor biology, drug doses and schedules may be optimized during early clinical development to improve anti-tumor effects in subsequent trials. Pharmacokinetic analysis of the PI3K inhibitor GDC-0941 at low (100 mg/kg) and high (800 mg/kg) doses in mice revealed that plasma levels peaked after 15-30 min (18.6 uM and 20.7 uM, respectively), and decreased to a plateau phase after 1 h that was maintained for 8 h with low-dose GDC-0941 (6.8-10.7 uM) and for 23 h with high-dose GDC-0941 (7.9-15 uM). Thus, GDC-0941 appears to be retained in a tissue compartment and slowly released back into plasma over time. Mice bearing MCF-7 tumors were treated with the anti-estrogen fulvestrant (5 mg) for three days, and then low- or high-dose GDC-0941, or 2 low doses of GDC-0941 12 hours apart, to assess pharmacodynamic effects and tumor cell response. PARP cleavage (marker of apoptosis) occurred within 1 h and 3 h of high- and low-dose treatments, respectively, and apoptosis increased over time. Phosphorylated AKT and S6 levels (markers of PI3K and mTORC1 activities) were maximally suppressed after 1 h and 3 h of high- and low-dose treatments, respectively, and returned to baseline within 16 h after low-dose treatment. In vitro analysis revealed that PI3K inhibition induced upregulation of growth factor receptors upstream of PI3K, indicating a requirement for sustained and robust PI3K inhibition. Re-treatment of mice with low-dose GDC-0941 after 12 h induced continued inhibition of PI3K and mTORC1 for >9 h, suggesting that twice daily low-dose treatment may be sufficient to continually inhibit PI3K. In contrast, high-dose GDC-0941 suppressed PI3K and mTORC1 for >24 h. Analysis of these doses and schedules on tumor growth is ongoing. Citation Format: Wei Yang, Jennifer R. Bean, Lloye Dillon, Laurent Salphati, Michelle Nannini, Todd W. Miller. Pharmacodynamic analysis of PI3K inhibition in breast tumors: A model to improve early clinical investigation of novel agents. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 5512. doi:10.1158/1538-7445.AM2014-5512" @default.
• W2000415450 created "2016-06-24" @default.
• W2000415450 creator A5000900890 @default.
• W2000415450 creator A5016875323 @default.
• W2000415450 creator A5028561152 @default.
• W2000415450 creator A5068764000 @default.
• W2000415450 creator A5078473824 @default.
• W2000415450 creator A5080163243 @default.
• W2000415450 date "2014-09-30" @default.
• W2000415450 modified "2023-09-25" @default.
• W2000415450 title "Abstract 5512: Pharmacodynamic analysis of PI3K inhibition in breast tumors: A model to improve early clinical investigation of novel agents" @default.
• W2000415450 doi "https://doi.org/10.1158/1538-7445.am2014-5512" @default.
• W2000415450 hasPublicationYear "2014" @default.
• W2000415450 type Work @default.
• W2000415450 sameAs 2000415450 @default.
• W2000415450 citedByCount "0" @default.
• W2000415450 crossrefType "proceedings-article" @default.
• W2000415450 hasAuthorship W2000415450A5000900890 @default.
• W2000415450 hasAuthorship W2000415450A5016875323 @default.
• W2000415450 hasAuthorship W2000415450A5028561152 @default.
• W2000415450 hasAuthorship W2000415450A5068764000 @default.
• W2000415450 hasAuthorship W2000415450A5078473824 @default.
• W2000415450 hasAuthorship W2000415450A5080163243 @default.
• W2000415450 hasConcept C111113717 @default.
• W2000415450 hasConcept C112705442 @default.
• W2000415450 hasConcept C121608353 @default.
• W2000415450 hasConcept C126322002 @default.
• W2000415450 hasConcept C143998085 @default.
• W2000415450 hasConcept C185592680 @default.
• W2000415450 hasConcept C190283241 @default.
• W2000415450 hasConcept C197934379 @default.
• W2000415450 hasConcept C2776166826 @default.
• W2000415450 hasConcept C2777164284 @default.
• W2000415450 hasConcept C2778504769 @default.
• W2000415450 hasConcept C2780482068 @default.
• W2000415450 hasConcept C530470458 @default.
• W2000415450 hasConcept C55493867 @default.
• W2000415450 hasConcept C71924100 @default.
• W2000415450 hasConcept C84606932 @default.
• W2000415450 hasConcept C86554907 @default.
• W2000415450 hasConcept C98274493 @default.
• W2000415450 hasConceptScore W2000415450C111113717 @default.
• W2000415450 hasConceptScore W2000415450C112705442 @default.
• W2000415450 hasConceptScore W2000415450C121608353 @default.
• W2000415450 hasConceptScore W2000415450C126322002 @default.
• W2000415450 hasConceptScore W2000415450C143998085 @default.
• W2000415450 hasConceptScore W2000415450C185592680 @default.
• W2000415450 hasConceptScore W2000415450C190283241 @default.
• W2000415450 hasConceptScore W2000415450C197934379 @default.
• W2000415450 hasConceptScore W2000415450C2776166826 @default.
• W2000415450 hasConceptScore W2000415450C2777164284 @default.
• W2000415450 hasConceptScore W2000415450C2778504769 @default.
• W2000415450 hasConceptScore W2000415450C2780482068 @default.
• W2000415450 hasConceptScore W2000415450C530470458 @default.
• W2000415450 hasConceptScore W2000415450C55493867 @default.
• W2000415450 hasConceptScore W2000415450C71924100 @default.
• W2000415450 hasConceptScore W2000415450C84606932 @default.
• W2000415450 hasConceptScore W2000415450C86554907 @default.
• W2000415450 hasConceptScore W2000415450C98274493 @default.
• W2000415450 hasLocation W20004154501 @default.
• W2000415450 hasOpenAccess W2000415450 @default.
• W2000415450 hasPrimaryLocation W20004154501 @default.
• W2000415450 hasRelatedWork W1540369222 @default.
• W2000415450 hasRelatedWork W1551477344 @default.
• W2000415450 hasRelatedWork W1799713393 @default.
• W2000415450 hasRelatedWork W1966789767 @default.
• W2000415450 hasRelatedWork W2046843048 @default.
• W2000415450 hasRelatedWork W2067125882 @default.
• W2000415450 hasRelatedWork W2070765493 @default.
• W2000415450 hasRelatedWork W2080518672 @default.
• W2000415450 hasRelatedWork W2082279433 @default.
• W2000415450 hasRelatedWork W2088029388 @default.
• W2000415450 hasRelatedWork W2089923741 @default.
• W2000415450 hasRelatedWork W2098609770 @default.
• W2000415450 hasRelatedWork W2106715939 @default.
• W2000415450 hasRelatedWork W2313789288 @default.
• W2000415450 hasRelatedWork W2319776459 @default.
• W2000415450 hasRelatedWork W2400910579 @default.
• W2000415450 hasRelatedWork W2403023578 @default.
• W2000415450 hasRelatedWork W2566021416 @default.
• W2000415450 hasRelatedWork W2762143865 @default.
• W2000415450 hasRelatedWork W2995354875 @default.
• W2000415450 isParatext "false" @default.
• W2000415450 isRetracted "false" @default.
• W2000415450 magId "2000415450" @default.
• W2000415450 workType "article" @default.